UAM
MRNA icon

UAS Asset Management’s Moderna MRNA Stock Holding History

UAS Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,750
Closed -$213K – 17
2023
Q2 		$213K Buy
+1,750
New +$233K 0.06% 16
2022
Q1 		– Sell
-5,050
Closed -$1.28M – 18
2021
Q4 		$1.28M Buy
5,050
+2,050
+68% +$599K 0.28% 13
2021
Q3 		$1.16M Buy
+3,000
New +$1.11M 0.3% 13

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

UAS Asset Management's MRNA Position: Q3 2023 in Review

UAS Asset Management sold out of Moderna (MRNA) in Q3 2023, closing a stake of 1,750 shares — an estimated $213K sold.

UAS Asset Management first reported a position in MRNA in Q3 2021 and held it in 3 quarters. The position peaked at $1.28M in Q4 2021. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • UAS Asset Management reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • UAS Asset Management sold 1,750 Moderna shares in Q3 2023, an estimated $213K.
  • UAS Asset Management first reported a position in Moderna in Q3 2021 and held it in 3 quarters.
  • UAS Asset Management's Moderna position peaked at $1.28M in Q4 2021.
  • 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on UAS Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.